Literature DB >> 18676387

Serotonin toxicity caused by an interaction between fentanyl and paroxetine.

Simon T Rang1, Jennifer Field, Colm Irving.   

Abstract

PURPOSE: To report a case of serotonin toxicity, presenting in the postoperative period, caused by an interaction between paroxetine (a selective serotonin reuptake inhibitor, SSRI) and fentanyl (a phenylpiperidine opioid). Serotonin toxicity precipitated by fentanyl is unusual and has not previously been described in combination with SSRIs in the perioperative setting. CLINICAL FEATURES: A 60-yr-old woman, established on paroxetine for depression, underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction. Fentanyl was administered for intraoperative and postoperative analgesia (1 mg intraoperatively, and 2.5 mg by infusion in the first 36 hr, postoperatively). She developed a vague affectation, intermittent agitation, bilateral hyper-reflexia, inducible clonus, and a period of hypertension, suggestive of serotonin toxicity. There was complete resolution after cessation of fentanyl and paroxetine.
CONCLUSION: The co-administration of SSRIs and fentanyl may precipitate serotonin toxicity. There must be consideration of this unusual interaction when administering fentanyl to patients established on SSRIs. Physicians should be vigilant of the features of serotonin toxicity developing in such patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676387     DOI: 10.1007/BF03016672

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  5 in total

Review 1.  [Polypharmacy and pain treatment].

Authors:  Markus Gosch; Birgit Böhmdorfer; Ursula Benvenuti-Falger; Peter Dovjak; Bernhard Iglseder; Monika Lechleitner; Ronald Otto; Regina E Roller; Ulrike Sommeregger
Journal:  Wien Med Wochenschr       Date:  2010-06

2.  [Analgesics in geriatric patients. Adverse side effects and interactions].

Authors:  Markus Gosch
Journal:  Z Gerontol Geriatr       Date:  2015-07       Impact factor: 1.281

3.  Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan; H Daniel Adams; Zhiyuan Ma
Journal:  Psychopharmacology (Berl)       Date:  2014-10-11       Impact factor: 4.530

4.  Effects of opioids on human serotonin transporters.

Authors:  M Barann; U M Stamer; M Lyutenska; F Stüber; H Bönisch; B Urban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-22       Impact factor: 3.000

5.  Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?

Authors:  Petra E Spies; J L W Hans Pot; Roel P J Willems; Jacqueline M Bos; Cornelis Kramers
Journal:  Eur J Hosp Pharm       Date:  2016-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.